4SC AG

Report Publication Announcement • Nov 17, 2015

News Details

Corporate | 17 November 2015 15:10

Announcement: 4SC AG to present at two upcoming investor conferences

DGAP-News: 4SC AG / Key word(s): Conference/Miscellaneous

2015-11-17 / 15:10

---

Announcement

4SC AG to present at two upcoming investor conferences

Planegg-Martinsried, Germany, 17 November 2015 – 4SC AG (Frankfurt, Prime Standard: VSC), a biotechnology company dedicated to the research and development of targeted small molecule drugs focusing on cancer, will present at the following investor conferences in November 2015.

Jefferies Autumn 2015 Global Healthcare Conference

Date: 18-19 November 2015

Location: London, UK

Participant: Enno Spillner, Chairman of the Management Board (CEO & CFO) of 4SC AG

German Equity Forum 2015

Date: 23-24 November 2015

Corporate Presentation: 23 November 2015, 2:30pm CET (room: Oslo)

Location: Frankfurt am Main, Germany

Participant: Enno Spillner, Chairman of the Management Board (CEO & CFO) of 4SC AG

End of release

About 4SC

4SC is a biotechnology company dedicated to the research and development of small-molecule drugs for treating diseases with high unmet medical needs focusing on cancer. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious than existing therapies, and provide a better quality of life. The Company’s pipeline comprises promising products that are in various stages of clinical development. 4SC’s aim is to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies. Founded in 1997, 4SC had a headcount of 69 employees (60 FTEs) at 30 September 2015. 4SC AG is listed on the Prime Standard of the Frankfurt Stock Exchange (ISIN DE000A14KL72).

Cautionary statement regarding forward-looking statements

This press release contains certain forward-looking statements. Any forward-looking statement applies only on the date of this press release. By their nature, forward-looking statements are subject to a number of known and unknown risks and uncertainties that may or may not occur in the future and as a result of which the actual results and performance may differ substantially from the expected future results or performance expressed or implied in the forward looking statements. No warranties or representations are made as to the accuracy, achievement or reasonableness of such statements, estimates or projections, and 4SC AG has no obligation to update any such information or to correct any inaccuracies herein or omission herefrom which may become apparent.

For more information please visit www.4sc.com or contact:

4SC AG

Jochen Orlowski, Corporate Communications & Investor Relations

jochen.orlowski(at)4sc.com, Tel.: +49-89-7007-6366

MC Services

Katja Arnold, Dorothea Schneider

katja.arnold(at)mc-services.eu, Tel.: +49-89-2102-2840

The Trout Group

Chad Rubin

crubin(at)troutgroup.com, Tel.: +1-646-378-2947

---

2015-11-17 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language:	English
Company:	4SC AG
	Am Klopferspitz 19a
	82152 Martinsried
	Germany
Phone:	+49 (0)89 7007 63-0
Fax:	+49 (0)89 7007 63-29
E-mail:	public@4sc.com
Internet:	www.4sc.de
ISIN:	DE000A14KL72
WKN:	A14KL7
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange

End of News	DGAP News Service

- - -
413969  2015-11-17